Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give...

|By:, SA News Editor

Quintiles Transnational and its owners plan to raise up to $788M in an NYSE IPO that will give the pharmaceuticals testing company a market cap of around $4.9B at the mid-point of a projected price range of $36-40 a share. Quintiles intends to sell 13.8M, while its shareholders, which include TPG and Bain, plan to offer 5.9M shares. Quintiles will trade under the ticker symbol Q. (previous)